临床试验

Werewolf Flow 50 During ACL Reconstruction

NCT：NCT04998656 · COMPLETED

NCT编号NCT04998656

状态COMPLETED

开始日期2021-07-12

完成时间2024-11-02

SponsorUniversity of Colorado, Denver (OTHER)

First posted2021-08-10

Last updated2026-09-14

简要摘要

The aim of this study is to compare the outcomes, ease of use, and cost of the Werewolf FLOW50 device to the institutional standard of care which is does not include the use of electrocautery devices during anterior cruciate ligament reconstruction (ACLR) surgery in patients 12-18 years of age using a randomized control trial design. The investigators hypothesize that a lower proportion of participants who undergo ACLR and are randomized to the Werewolf FLOW50 procedure will experience post-operative arthrofibrosis compared to those randomized to standard of care (control group).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。